5.16
Design Therapeutics Inc Borsa (DSGN) Ultime notizie
Will Design Therapeutics Inc. continue its uptrendWeekly Volume Report & Capital Protection Trading Alerts - Newser
What MACD and RSI say about Design Therapeutics Inc.July 2025 Gainers & Weekly High Return Forecasts - Newser
Can Traders Expect Breakout From Design Therapeutics Inc. This WeekStock Surge & Risk Controlled Daily Trade Plans - beatles.ru
Published on: 2025-08-14 04:36:30 - Newser
Is Design Therapeutics Inc. stock a growth or value playJuly 2025 Earnings & Expert Verified Movement Alerts - Newser
Design Therapeutics Inc. Company’s Quarterly Earnings Growth: What the Numbers SayTrade Risk Report & Target Return Focused Stock Picks - Newser
News impact scoring models applied to Design Therapeutics Inc.July 2025 Decliners & Weekly Market Pulse Updates - Newser
Can momentum traders help lift Design Therapeutics Inc.Share Buyback & Free Expert Approved Momentum Trade Ideas - Newser
Will Design Therapeutics Inc. rebound enough to break even2025 Macro Impact & Free Safe Entry Trade Signal Reports - Newser
Will Design Therapeutics Inc. stock recover after recent drop2025 Historical Comparison & Expert Verified Stock Movement Alerts - Newser
Is Design Therapeutics Inc. stock ready for a breakoutWeekly Profit Recap & Weekly Watchlist of Top Performers - Newser
Price action breakdown for Design Therapeutics Inc.Portfolio Return Summary & High Conviction Investment Ideas - Newser
Price action breakdown for Design Therapeutics Inc. [July 2025 Final Week]Fast Entry High Yield Tips - Newser
Technical analysis overview for Design Therapeutics Inc. stockWeekly Gains Report & Verified Swing Trading Watchlist - Newser
Using Bollinger Bands to evaluate Design Therapeutics Inc.Dollar Strength & Real-Time Buy Signal Alerts - Newser
Published on: 2025-08-13 11:59:52 - 선데이타임즈
How to manage a losing position in Rapport Therapeutics Inc.Strategy Builder for Growth Focused Traders - Newser
KORU Medical Systems And 2 Other Penny Stocks To Watch For Growth - simplywall.st
Advanced analytics toolkit walkthrough for Design Therapeutics Inc.Swing Trade Picks with High Potential - Newser
Heatmap analysis for Design Therapeutics Inc. and competitorsFree High Yield Stocks With Buy Confirmation - Newser
What momentum shifts mean for Design Therapeutics Inc.Risk Aware Trading Ideas with Alert Levels - Newser
How sentiment analysis helps forecast Design Therapeutics Inc.Free Low Drawdown Real Time Trading Tips - Newser
Trend analysis for Design Therapeutics Inc. this weekNeural Network Based Equity Prediction System - Newser
Long term hold vs stop loss in Design Therapeutics Inc.Insider Strategy for High Conviction Picks - Newser
How to escape a deep drawdown in Design Therapeutics Inc.Smart Risk Entry Zone Technical Analysis - Newser
What high frequency data says about Design Therapeutics Inc.AI Screener for Daily Stock Forecast - Newser
Design Therapeutics, Inc. shares rise 10.05% intraday after 4DMT reported positive 60-week results from 4D-150 SPECTRA clinical trial in DME. - AInvest
What makes Design Therapeutics Inc. stock attractive to long term investorsPrice Movement and Market Sentiment Analysis - Newser
Risk vs reward if holding onto Design Therapeutics Inc.Buy Candidate Summary Based on Fundamentals - Newser
What technical models suggest about Design Therapeutics Inc.’s comebackFree Smart Trend Trading with Weekly Signals - Newser
What makes Design Therapeutics Inc. stock price move sharplyReal Chart Based Opportunity Identification - Newser
Machine Learning Models Forecast Design Therapeutics Inc. UptickEntry Plan for Oversold Reversal Stocks Released - metal.it
Backtesting results for Design Therapeutics Inc. trading strategiesFree AI Screening for Swing Trade Picks - Newser
Using flow based indicators on Design Therapeutics Inc.Technical Reversal Setup with Risk Limits - Newser
Will breakout in Design Therapeutics Inc. lead to full recoveryHistorical Stock Summary and ROI Review - Newser
Has Design Therapeutics Inc. found a price floorFree ROI Boosting Trade Opportunity Calendar - Newser
Design Therapeutics Inc reports results for the quarter ended June 30Earnings Summary - TradingView
Design Therapeutics Advances GeneTAC Programs Amid FDA Hold, Reports Q2 Financial Results - AInvest
Design Therapeutics reports Q2 EPS (34c), consensus (33c) - TipRanks
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):